Hangzhou Meiya Pharmaceutical Co., Ltd.

　　Hangzhou Meiya Pharmaceutical Co., Ltd. was established in March 2006, mainly engaged in nucleotide products. It is a NEEQ listed company (stock code: 833650) integrating R&D, production and sales. The company was developed from Hangzhou Meiya Biotechnology Co., Ltd. which was established in 1998, and has been focusing on the development, production and process improvement of the preparation process of nucleotide products. In November 2012, a wholly-owned subsidiary-Shanghai Ucosa Biotechnology Co., Ltd. was established as the company's marketing center. In January 2014, a wholly-owned production base and subsidiary, Meiya Pharmaceutical Haian Co., Ltd. was established, with a total investment of more than 120 million yuan. The company has a pharmaceutical production license and a production workshop meeting GMP requirements of nearly 10,000 square meters.